Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
出版年份 2017 全文链接
标题
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume 32, Issue 7, Pages 1066-1073
出版商
Wiley
发表日期
2017-05-26
DOI
10.1002/mds.27001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
- (2016) Lucilla Parnetti et al. Biomarkers in Medicine
- Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
- (2016) Brit Mollenhauer et al. JOURNAL OF NEUROCHEMISTRY
- Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
- (2016) Sara Hall et al. MOVEMENT DISORDERS
- Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
- (2016) Xiao-Yan Qin et al. JAMA Neurology
- Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies
- (2015) Urmi Sengupta et al. BIOLOGICAL PSYCHIATRY
- The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
- (2015) Erdinç Dursun et al. JOURNAL OF NEUROIMMUNOLOGY
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease
- (2015) Ane Løvli Stav et al. PARKINSONISM & RELATED DISORDERS
- Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study
- (2014) Shu-yang Yu et al. BMC Neurology
- Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process
- (2014) Rafael González-Redondo et al. BRAIN
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The neurobiological basis of cognitive impairment in Parkinson's disease
- (2014) Glenda M. Halliday et al. MOVEMENT DISORDERS
- Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
- (2014) Peng Tang et al. Oxidative Medicine and Cellular Longevity
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment
- (2013) Daniel Lindqvist et al. BRAIN BEHAVIOR AND IMMUNITY
- Microglia, Amyloid and Glucose Metabolism in Parkinson’s Disease with and without Dementia
- (2013) Paul Edison et al. NEUROPSYCHOPHARMACOLOGY
- Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
- (2013) Malin Wennström et al. PLoS One
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
- (2012) Daniel Lindqvist et al. PLoS One
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
- (2011) Yu Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- The roles of TNF in brain dysfunction and disease
- (2010) Ian A. Clark et al. PHARMACOLOGY & THERAPEUTICS
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance
- (2009) Paula Scalzo et al. NEUROSCIENCE LETTERS
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
- (2008) Bogdan Brodacki et al. NEUROSCIENCE LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now